AMD supplements may accelerate the disease in some people
September 5th 2014Nutritional supplements meant to slow the progression of age-related macular degeneration (AMD) may actually accelerate the disease in people with certain genotypes, according to research recently presented at the American Society of Retina Specialists annual meeting.
Delayed or immediate laser treatment for DME yield similar results
September 5th 2014According to research recently presented at the American Society of Retina Specialists annual meeting, focal or grid laser treatment that coincides with the initiation of intravitreal ranibizumab for the treatment of diabetic macular edema (DME) shows results no better than when laser treatment is deferred for 24 weeks or more.
Oraya Therapeutics receives grant to study wet AMD treatment
September 5th 2014The National Institutes of Health recently awarded a $215,000 Small Business Technology Transfer Grant to Oraya Therapeutics to investigate how its therapy and gold nanoparticles affect the treatment of wet age-related macular degeneration (AMD).
OD Q&A: Hunter W. Chapman, AOSA Trustee, AOA-PAC National Liaison, SCO Student Ambassador
August 26th 2014I got involved legislatively before I even attended optometry school. I went to LSU, which is in the state capitol, Baton Rouge. One of the optometrist I was shadowing at the time was going to a committee hearing for a nondiscriminatory bill for reimbursement rates for optometrists.